MIS-C Treatment: Is IVIG Always Necessary?

• Main Authors: Francesco Licciardi (Author), Letizia Baldini (Author), Marta Dellepiane (Author), Carlotta Covizzi (Author), Roberta Mogni (Author), Giulia Pruccoli (Author), Cecilia Orsi (Author), Ivana Rabbone (Author), Emilia Parodi (Author), Federica Mignone (Author), Davide Montin (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: MIS-C is a potentially severe inflammatory syndrome associated with SARS-CoV-2 exposure. Intravenous immunoglobulin (IVIG) is considered the first-tier therapy, but it implies infusion of large fluid volumes that may worsen cardiac function.Patients and Methods: Since April 2020, we have...